Shalini Varma
Psychiatry · Kenosha, WINPI 1760648406
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 475 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 475 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Vanda Pharmaceuticals Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Lundbeck LLC$1K
- Neurocrine Biosciences, Inc.$993
- Otsuka America Pharmaceutical, Inc.$571
- plus $3K from 20 others
What the payments were for
- Food & beverage$11,574100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 85 | $2,329 |
| Vanda Pharmaceuticals Inc. | 63 | $1,552 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 55 | $1,548 |
| Lundbeck LLC | 65 | $1,335 |
| Neurocrine Biosciences, Inc. | 36 | $993 |
| Otsuka America Pharmaceutical, Inc. | 30 | $571 |
| Axsome Therapeutics, Inc. | 20 | $530 |
| Avanir Pharmaceuticals, Inc. | 12 | $428 |
| AbbVie(2 entities) | 18 | $349 |
| Ironshore Pharmaceuticals Inc. | 20 | $326 |
| Idorsia Pharmaceuticals US Inc | 13 | $218 |
| E.r. Squibb & Sons, L.L.C. | 8 | $208 |
| Johnson & Johnson | 10 | $194 |
| Corium, LLC | 8 | $174 |
| Teva Pharmaceuticals USA, Inc. | 3 | $164 |
| Jazz Pharmaceuticals Inc. | 8 | $150 |
| Eisai Inc. | 5 | $119 |
| Neuronetics, Inc. | 1 | $82 |
| OWP Pharmaceuticals, Inc. | 3 | $70 |
| Biogen | 3 | $65 |
| Brainsway USA Inc | 1 | $51 |
| Alkermes, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Merck | 2 | $24 |
| Neos Therapeutics, LP | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,586 in reported general payments places this provider in the 95th percentile of 543 psychiatry providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 13 | $877 |
| Bupropion XlBupropion Hcl | 12 | $368 |
| Mirtazapine | 31 | $211 |
| Duloxetine Hcl | 24 | $197 |
| Trazodone Hcl | 23 | $172 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 29 | $141 |
| Sertraline Hcl | 45 | $116 |
| Fluoxetine Hcl | 16 | $115 |
| Buspirone Hcl | 23 | $80 |
| Lamotrigine | 19 | $53 |
| Clonidine Hcl | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Kenosha
- Ronald RubinKenosha$5K
- Scott WienerGreenfield$1.4M
- Joseph BergsRacine$346K
- Royle EenigenburgJuneau$344K
- Thomas IlicMilwaukee$324K
- Jay WinstonMilwaukee$238K
- Joseph BurgarinoMilwaukee$111K
- Sobia Kirmani MoeMadison$104K
- Jacob BehrensMilwaukee$94K
- Ned KalinMadison$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.